Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare
Eterna Therapeutics Inc. Shareholder Equity 2010–2024
Eterna Therapeutics Inc. annual shareholder equity history from 2010 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Eterna Therapeutics Inc. shareholder equity as of December 31, 2024: 1.7M, a 23.82% decrease year-over-year.
- Eterna Therapeutics Inc. shareholder equity for 2024 were 1.7M, a 23.82% decrease from 2023.
- Eterna Therapeutics Inc. shareholder equity for 2023 were 2.2M, a 81.56% decrease from 2022.
- Eterna Therapeutics Inc. shareholder equity for 2022 were 12.1M, a 58.08% increase from 2020.
- Eterna Therapeutics Inc. shareholder equity for 2020 were 7.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eterna Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $2 |
| 2023 | $2 |
| 2022 | $12 |
| 2020 | $8 |
| 2019 | $10 |
| 2018 | $7 |
| 2017 | $6 |
| 2016 | $4 |
| 2015 | $4 |
| 2014 | $11 |
| 2013 | $9 |
| 2012 | $8 |
| 2011 | $6 |
| 2010 | $9 |
Eterna Therapeutics Inc. Shareholder Equity — FAQ
Eterna Therapeutics Inc. (ERNA) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ERNA's shareholder equity history?
The chart and table above show Eterna Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.